These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18997326)

  • 1. Crystallization and preliminary neutron diffraction studies of HIV-1 protease cocrystallized with inhibitor KNI-272.
    Matsumura H; Adachi M; Sugiyama S; Okada S; Yamakami M; Tamada T; Hidaka K; Hayashi Y; Kimura T; Kiso Y; Kitatani T; Maki S; Yoshikawa HY; Adachi H; Takano K; Murakami S; Inoue T; Kuroki R; Mori Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Nov; 64(Pt 11):1003-6. PubMed ID: 18997326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization of porcine pancreatic elastase and a preliminary neutron diffraction experiment.
    Kinoshita T; Tamada T; Imai K; Kurihara K; Ohhara T; Tada T; Kuroki R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):315-7. PubMed ID: 17401204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of HIV-1 protease in complex with potent inhibitor KNI-272 determined by high-resolution X-ray and neutron crystallography.
    Adachi M; Ohhara T; Kurihara K; Tamada T; Honjo E; Okazaki N; Arai S; Shoyama Y; Kimura K; Matsumura H; Sugiyama S; Adachi H; Takano K; Mori Y; Hidaka K; Kimura T; Hayashi Y; Kiso Y; Kuroki R
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4641-6. PubMed ID: 19273847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neutron crystallographic analysis of a rubredoxin mutant at 1.6 A resolution.
    Chatake T; Kurihara K; Tanaka I; Tsyba I; Bau R; Jenney FE; Adams MW; Niimura N
    Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1364-73. PubMed ID: 15272158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid X-ray diffraction analysis of HIV-1 protease-inhibitor complexes: inhibitor exchange in single crystals of the bound enzyme.
    Munshi S; Chen Z; Li Y; Olsen DB; Fraley ME; Hungate RW; Kuo LC
    Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):1053-60. PubMed ID: 9757136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidomimetic inhibitors complexed with HIV-1 protease: crystallisation for X-ray diffraction studies.
    Dohnálek J; Hasek J; Brynda J; Fábry M; Sedlácek J; Konvalinka J; Hradilek M; Soucek M; Adams MJ; Naylor CE
    Gen Physiol Biophys; 1998 Jun; 17 Suppl 1():9-11. PubMed ID: 9789742
    [No Abstract]   [Full Text] [Related]  

  • 7. [Kynostatin (KNI)-272--a rationally designed tripeptide inhibitor of HIV protease].
    Kiso Y
    Nihon Rinsho; 1993 Sep; 51 Suppl():139-45. PubMed ID: 8271377
    [No Abstract]   [Full Text] [Related]  

  • 8. Crystallization and preliminary neutron analysis of the dissimilatory sulfite reductase D (DsrD) protein from the sulfate-reducing bacterium Desulfovibrio vulgaris.
    Chatake T; Mizuno N; Voordouw G; Higuchi Y; Arai S; Tanaka I; Niimura N
    Acta Crystallogr D Biol Crystallogr; 2003 Dec; 59(Pt 12):2306-9. PubMed ID: 14646103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
    Kiso Y
    Biopolymers; 1996; 40(2):235-44. PubMed ID: 8785365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization of a large single crystal of cubic insulin for neutron protein crystallography.
    Maeda M; Chatake T; Tanaka I; Ostermann A; Niimura N
    J Synchrotron Radiat; 2004 Jan; 11(Pt 1):41-4. PubMed ID: 14646130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272.
    Wang YX; Freedberg DI; Yamazaki T; Wingfield PT; Stahl SJ; Kaufman JD; Kiso Y; Torchia DA
    Biochemistry; 1996 Aug; 35(31):9945-50. PubMed ID: 8756455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of HIV-1 protease with KNI-272: a transition state mimetic inhibitor containing allophenylnorstatine.
    Baldwin ET; Bhat TN; Gulnik S; Liu B; Kiso Y; Mitsuya H; Erickson JW
    Adv Exp Med Biol; 1995; 362():445-9. PubMed ID: 8540355
    [No Abstract]   [Full Text] [Related]  

  • 13. Towards investigation of the inhibitor-recognition mechanisms of drug-target proteins by neutron crystallography.
    Kuroki R; Okazaki N; Adachi M; Ohhara T; Kurihara K; Tamada T
    Acta Crystallogr D Biol Crystallogr; 2010 Nov; 66(Pt 11):1126-30. PubMed ID: 21041926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structural and thermodynamic escape mechanism from a drug resistant mutation of the HIV-1 protease.
    Vega S; Kang LW; Velazquez-Campoy A; Kiso Y; Amzel LM; Freire E
    Proteins; 2004 May; 55(3):594-602. PubMed ID: 15103623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
    Lu Y; Yang CY; Wang S
    J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational titration analysis of a multiprotic HIV-1 protease-ligand complex.
    Spyrakis F; Fornabaio M; Cozzini P; Mozzarelli A; Abraham DJ; Kellogg GE
    J Am Chem Soc; 2004 Sep; 126(38):11764-5. PubMed ID: 15382890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from atomic-resolution X-ray structures of chemically synthesized HIV-1 protease in complex with inhibitors.
    Johnson EC; Malito E; Shen Y; Pentelute B; Rich D; Florián J; Tang WJ; Kent SB
    J Mol Biol; 2007 Oct; 373(3):573-86. PubMed ID: 17869270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected binding mode of a cyclic sulfamide HIV-1 protease inhibitor.
    Bäckbro K; Löwgren S; Osterlund K; Atepo J; Unge T; Hultén J; Bonham NM; Schaal W; Karlén A; Hallberg A
    J Med Chem; 1997 Mar; 40(6):898-902. PubMed ID: 9083478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
    Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):472-6. PubMed ID: 11223536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary neutron and ultrahigh-resolution X-ray diffraction studies of the aspartic proteinase endothiapepsin cocrystallized with a gem-diol inhibitor.
    Tuan HF; Erskine P; Langan P; Cooper J; Coates L
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Dec; 63(Pt 12):1080-3. PubMed ID: 18084100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.